Short Title: MK1026-010
Enrollment Status: Recruiting
NCT #: NCT05947851
Specialty Area: Oncology
Condition Studied: Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL)
Age Groups: Adult; Older Adult
Phase: II
This study is looking at new treatment combinations for people with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL) who have already received at least one prior treatment. The goal of the study is to compare these treatments and determine which approach may be more effective for managing the disease.
Confirmed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL) whose disease has returned or not responded after at least one prior treatment.
Completing a screening process that includes medical history review, physical exams, blood tests, and possibly imaging scans to confirm eligibility.
Location: Renown Health, Office of Clinical Research
Address:
Complete Study Details: https://clinicaltrials.gov/study/NCT05947851
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.
